Cargando…
Serum sialylation changes in cancer
Cancer is a major cause of death in both developing and developed countries. Early detection and efficient therapy can greatly enhance survival. Aberrant glycosylation has been recognized to be one of the hallmarks of cancer as glycans participate in many cancer-associated events. Cancer-associated...
Autores principales: | Zhang, Zejian, Wuhrer, Manfred, Holst, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916985/ https://www.ncbi.nlm.nih.gov/pubmed/29680984 http://dx.doi.org/10.1007/s10719-018-9820-0 |
Ejemplares similares
-
Serum Linkage-Specific Sialylation Changes Are Potential Biomarkers for Monitoring and Predicting the Recurrence of Papillary Thyroid Cancer Following Thyroidectomy
por: Cao, Zhen, et al.
Publicado: (2022) -
Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarcinoma cells
por: Zhang, Jing, et al.
Publicado: (2022) -
Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers
por: Trinchera, Marco, et al.
Publicado: (2017) -
N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines
por: Holst, Stephanie, et al.
Publicado: (2019) -
The Role of Sialyl-Tn in Cancer
por: Munkley, Jennifer
Publicado: (2016)